ОБЗОР2025 · pp. 21–31
Evert L.S., Potupchik T.V., Veselova O.F., Svetlakova I.S., Panchenko B.A., Kudasheva R.R., Melnikova A.N.
Objective. To analyze the potential risks and technological limitations of using genome editing methods in neurodegenerative diseases, as well as to assess the prospects for their implementation in clinical practice. Material and methods. A systematic analysis…
ОБЗОР2025 · pp. 3–15
Seliverstov P.V., Ananyan M.A., Marchenko S.D., Stepanov M.R., Voznesenskaya E.A., Ilina K.V., Lyapustin K.Yu.
Introduction. Nanotechnology represents an innovative direction in cancer drug development, enabling the creation of effective drug delivery systems with enhanced therapeutic properties. Objective. To analyze the main types of nanoparticles used in oncology, e…